Xiaoqu Hu
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery
- Topics
- Cancer-related molecular mechanisms research (9 papers)MicroRNA in disease regulation (5 papers)RNA modifications and cancer (5 papers)
- Journals
- CellAdvanced MaterialsPLoS ONE
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Xiaoqu Hu
34 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 1.6k
- Cancer Research 1.3k
- Oncology 632
- Endocrinology, Diabetes and Metabolism 203
- Surgery 153
Countries citing papers authored by Xiaoqu Hu
This map shows the geographic impact of Xiaoqu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqu Hu more than expected).
Fields of papers citing papers by Xiaoqu Hu
This network shows the impact of papers produced by Xiaoqu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqu Hu. The network helps show where Xiaoqu Hu may publish in the future.
Co-authorship network of co-authors of Xiaoqu Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqu Hu. A scholar is included among the top collaborators of Xiaoqu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqu Hu. Xiaoqu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 10 | |
| 10 | 2 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 39 | |
| 14 | [Targeted detecting HER2 expression with recombinant anti HER2 ScFv-GFP fusion antibody]. | 1 |
| 15 | 8 | |
| 16 | 145 | |
| 17 | 37 | |
| 18 | 1 | |
| 19 | 15 | |
| 20 | 56 |
About Xiaoqu Hu
Xiaoqu Hu is a scholar working on Cancer Research, Biological Psychiatry and Parasitology, having authored 35 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.6k citations) and Oncology (632 citations). Xiaoqu Hu has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Chang Gong, Erwei Song, Fengyan Yu, Fengxi Su, Judy Lieberman, Pengcheng Zhu, Herui Yao, Yijun Huang, Xiaoqin Zhang and Qiuhui Pan. Their work appears in journals such as Cell, Advanced Materials and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.